| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | CFO
1 company
Cavan John T serves as a Chief Financial Officer at HEPA. Across recent SEC filings that breaks down to 3 buys and 0 sells. Those positions are worth an estimated $30K at current prices.
The biggest single holding is HEPA (~$30K) as Chief Financial Officer. Net of sales, the recent Form 4 record there shows accumulation of 34,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2021 | HEPA Hepion Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 10,000 | $2.00 | $20,000.00 | +208.3% | |
| Nov 25, 2020 | HEPA Hepion Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 4,500 | $1.62 | $7,290.00 | +1,500% | |
| Jun 20, 2017 | HEPA Hepion Pharmaceuticals, Inc. | CFO | Buy | 20,000 | $0.65 | $13,000.00 | New |